吲哚瑞酯

吲哚瑞酯
識別資訊
	IUPAC命名法 methyl 3-amino-2-(5-methoxy-1H-indol-3-yl)propanoate; ;
CAS號	73758-06-2
PubChem CID	71987;
ChemSpider	64989 ;
UNII	AV9L041QA4;
CompTox Dashboard（英語：CompTox Chemicals Dashboard） (EPA)	DTXSID2048400 ;
化學資訊
化學式	C13H16N2O3
摩爾質量	248.277 g/mol
3D模型（JSmol（英語：JSmol））	交互式圖像;
	SMILES COC(=O)C(CN)c1cnc(ccc2OC)c1c2;

吲哚瑞酯（英語：Indorenate，TR-3369）是一種色胺衍生物，常作為5-HT_1A（英語：5-HT1A receptor）、5-HT_1B（英語：5-HT1B receptor）、5-HT_2C（英語：5-HT2C receptor）等血清素受體的激動劑。它具有抗焦慮、降壓和降食慾（英語：anorectic）的作用，主要是通過激動5-HT_1A受體來完成，但5-HT_1B和5-HT_2C也有可能起一定作用，另外一些非血清素受體也可能是它的靶標。^[1]^[2]^[3]^[4]^[5]^[6]^[7]^[8]^[9]

另見

5-甲氧基色胺

參考文獻

^ Antonaccio MJ, Kerwin L. On the effects and mechanism of action of the antihypertensive agent TR 3369 (5-methoxytryptamine beta-methylcarboxylate) in spontaneously hypertensive rats. Journal of Cardiovascular Pharmacology. 1981, 3 (6): 1306–11. PMID 6173531.
^ Schoeffter P, Hoyer D. Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus. British Journal of Pharmacology. November 1988, 95 (3): 975–85. PMC 1854240  . PMID 3207999.
^ Fernández-Guasti A, Escalante A, Hong E, Agmo A. Behavioural actions of the serotonergic anxiolytic indorenate. Pharmacology, Biochemistry, and Behavior. September 1990, 37 (1): 83–8. PMID 1979877. doi:10.1016/0091-3057(90)90045-J.
^ López Cabrera M, Velázquez Martínez DN, Prado R, García G, Ortiz R. Effects of the intracerebroventricular administration of indorenate and fenfluramine on spontaneous behavior and food intake in rats. Proceedings of the Western Pharmacology Society. 1991, 34: 465–8. PMID 1788330.
^ Velázquez-Martínez DN, López Cabrera M, Sánchez H, Ramírez JI, Hong E. Discriminative stimulus properties of indorenate, a serotonin agonist. Journal of Psychiatry & Neuroscience : JPN. March 1999, 24 (2): 122–30. PMC 1188992  . PMID 10212554.
^ Sánchez H, Velázquez-Martínez DN. Discriminative stimulus properties of indorenate, a 5-HT1A, 5-HT1B and 5-HT2C agonist: a study in rats. Journal of Psychopharmacology (Oxford, England). March 2001, 15 (1): 29–36. PMID 11277605.
^ Miranda F, Orozco G, Velázquez-Martínez DN. Full substitution of the discriminative cue of a 5-HT(1A/1B/2C) agonist with the combined administration of a 5-HT(1B/2C) and a 5-HT(1A) agonist. Behavioural Pharmacology. July 2002, 13 (4): 303–11. PMID 12218511.
^ Miranda F, Hong E, Sánchez H, Velázquez-Martínez DN. Further evidence that the discriminative stimulus properties of indorenate are mediated by 5-HT 1A/1B/2C receptors. Pharmacology, Biochemistry, and Behavior. January 2003, 74 (2): 371–80. PMID 12479957. doi:10.1016/S0091-3057(02)01010-9.
^ López-Meraz ML, Neri-Bazán L, Rocha L. Indorenate modifies a1-adrenergic and benzodiazepine receptor binding in the rat brain: an autoradiography study. The Journal of Pharmacy and Pharmacology. September 2006, 58 (9): 1243–8. PMID 16945183. doi:10.1211/jpp.58.9.0011.

[pmid6173531-1] Antonaccio MJ, Kerwin L. On the effects and mechanism of action of the antihypertensive agent TR 3369 (5-methoxytryptamine beta-methylcarboxylate) in spontaneously hypertensive rats. Journal of Cardiovascular Pharmacology. 1981, 3 (6): 1306–11. PMID 6173531.

[pmid3207999-2] Schoeffter P, Hoyer D. Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus. British Journal of Pharmacology. November 1988, 95 (3): 975–85. PMC 1854240  . PMID 3207999.

[pmid1979877-3] Fernández-Guasti A, Escalante A, Hong E, Agmo A. Behavioural actions of the serotonergic anxiolytic indorenate. Pharmacology, Biochemistry, and Behavior. September 1990, 37 (1): 83–8. PMID 1979877. doi:10.1016/0091-3057(90)90045-J.

[pmid1788330-4] López Cabrera M, Velázquez Martínez DN, Prado R, García G, Ortiz R. Effects of the intracerebroventricular administration of indorenate and fenfluramine on spontaneous behavior and food intake in rats. Proceedings of the Western Pharmacology Society. 1991, 34: 465–8. PMID 1788330.

[pmid10212554-5] Velázquez-Martínez DN, López Cabrera M, Sánchez H, Ramírez JI, Hong E. Discriminative stimulus properties of indorenate, a serotonin agonist. Journal of Psychiatry & Neuroscience : JPN. March 1999, 24 (2): 122–30. PMC 1188992  . PMID 10212554.

[pmid11277605-6] Sánchez H, Velázquez-Martínez DN. Discriminative stimulus properties of indorenate, a 5-HT1A, 5-HT1B and 5-HT2C agonist: a study in rats. Journal of Psychopharmacology (Oxford, England). March 2001, 15 (1): 29–36. PMID 11277605.

[pmid12218511-7] Miranda F, Orozco G, Velázquez-Martínez DN. Full substitution of the discriminative cue of a 5-HT(1A/1B/2C) agonist with the combined administration of a 5-HT(1B/2C) and a 5-HT(1A) agonist. Behavioural Pharmacology. July 2002, 13 (4): 303–11. PMID 12218511.

[pmid12479957-8] Miranda F, Hong E, Sánchez H, Velázquez-Martínez DN. Further evidence that the discriminative stimulus properties of indorenate are mediated by 5-HT 1A/1B/2C receptors. Pharmacology, Biochemistry, and Behavior. January 2003, 74 (2): 371–80. PMID 12479957. doi:10.1016/S0091-3057(02)01010-9.

[pmid16945183-9] López-Meraz ML, Neri-Bazán L, Rocha L. Indorenate modifies a1-adrenergic and benzodiazepine receptor binding in the rat brain: an autoradiography study. The Journal of Pharmacy and Pharmacology. September 2006, 58 (9): 1243–8. PMID 16945183. doi:10.1211/jpp.58.9.0011.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

[9]

識別資訊

IUPAC命名法 methyl 3-amino-2-(5-methoxy-1H-indol-3-yl)propanoate
CAS號	73758-06-2 ^Y
PubChem CID	71987
ChemSpider	64989^N
UNII	AV9L041QA4
CompTox Dashboard（英語：CompTox Chemicals Dashboard） (EPA)	DTXSID2048400
化學資訊
化學式	C₁₃H₁₆N₂O₃
摩爾質量	248.277 g/mol
3D模型（JSmol（英語：JSmol））	交互式圖像
SMILES COC(=O)C(CN)c1cnc(ccc2OC)c1c2